Urteste S.A. Logo

Urteste S.A.

URT | WAR

Overview

Corporate Details

ISIN(s):
PLURTST00010 (+1 more)
LEI:
259400Q4S6JIKFQHGU06
Country:
Poland
Address:
Gdańsk Starodworska 1, 80-137 Gdańsk
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Urteste S.A. is a research and development company specializing in innovative technology for the early detection of cancer. The company focuses on developing non-invasive, in vitro diagnostic (IVD) tests based on a proprietary enzymatic method. Its core innovation is a platform designed to detect multiple types of cancer at an early stage from a single urine sample. The technology is also intended to be used for monitoring the effects of cancer treatment.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Urteste S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-05 16:08
Report Publication Announcement
Uzyskanie ochrony patentowej od Urzędu Patentowego Rzeczypospolitej Polskiej na…
Polish 1.2 KB
2025-08-01 15:12
Board/Management Information
BIO - Przemysław Mencel
Polish 117.1 KB
2025-08-01 15:12
Board/Management Information
Powołanie Członka Rady Nadzorczej - Content (PL)
Polish 1.2 KB
2025-07-31 20:13
Board/Management Information
Rezygnacja Członka Rady Nadzorczej - Content (PL)
Polish 446 bytes
2025-07-25 13:21
Regulatory News Service
Zawarcie umowy z firmą BIOTYPE GmbH na produkcję testu Panuri - Content (PL)
Polish 1.9 KB
2025-06-30 11:20
Regulatory News Service
Przyznanie ochrony patentowej od Urzędu Patentowego w Indonezji na wynalazek w …
Polish 913 bytes
2025-06-26 11:19
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 1.4 KB
2025-06-25 18:17
Board/Management Information
Życiorysy Członków RN
Polish 57.1 KB
2025-06-25 18:17
Post-Annual General Meeting Information
Powołanie członków Rady Nadzorczej Emitenta na nową kadencję - Content (PL)
Polish 1.3 KB
2025-06-25 17:22
Post-Annual General Meeting Information
Uchwały ZWZ
Polish 252.3 KB
2025-06-25 17:22
Post-Annual General Meeting Information
Treść uchwał podjętych podczas obrad Zwyczajnego Walnego Zgromadzenia w dniu 25…
Polish 655 bytes
2025-06-23 08:42
Regulatory News Service
Zakończenie prac rozwojowych i osiągnięcie gotowości technologicznej do rozpocz…
Polish 3.0 KB
2025-05-29 17:28
Quarterly Report
Raport kwartalny IQ2025
Polish 1.7 MB
2025-05-28 15:17
Audit Report / Information
Sprawozdanie o wynagrodzeniach - Raport Biegłego Rewidenta
Polish 304.1 KB
2025-05-28 15:17
Remuneration Information
Sprawozdanie o wynagrodzeniach członków Zarządu i RN
Polish 681.1 KB

Automate Your Workflow. Get a real-time feed of all Urteste S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Urteste S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Kancera Logo
Develops drugs targeting the fractalkine axis for severe inflammation and resistant cancers.
Sweden KAN
Lidds AB Logo
Develops a drug delivery platform for local, sustained-release oncology treatments.
Sweden LIDDS
Lineage Cell Therapeutics Inc. Logo
Developing off-the-shelf cell therapies to restore function in neurological & retinal diseases.
Israel LCTX
Lipidor AB Logo
Develops topical skin disease drugs using a lipid-based drug delivery platform.
Sweden LIPI
Lipigon Pharmaceuticals AB Logo
Develops RNA and small-molecule drugs for rare, lipid-related disorders.
Sweden LPGO
Lipum AB Logo
Develops novel antibody therapies for chronic inflammatory diseases like rheumatoid arthritis.
Sweden LIPUM
LYSOGENE Logo France LYS
Lytix Biopharma AS Logo
Develops oncolytic peptides that kill cancer cells and stimulate an anti-tumor immune response.
Norway LYTIX
Matricelf Ltd. Logo
Engineering autologous 3D tissue implants from patient cells to treat spinal cord injuries.
Israel MTLF
Mazaro N.V. Logo
Engineering patented, high-efficiency transmissions for vehicles and industrial drivelines.
Belgium MLMAZ